☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware | 86-1403778 | |||
(State or other jurisdiction of incorporation) | ( | Identification |
20 University Road | ||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
SAIL SM (Stakeholder Aligned Initial Listing) securities, each consisting of one share ofone-fifth of one redeemable warrant to acquireone share of Class A Common Stock | REVHU | The | ||
Class A Common Stock included as part of the SAIL SM securities | REVH | The | ||
Redeemable Warrants included as part of the SAIL SM securities, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 | REVHW | The |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Assets: | ||||
Current assets: | ||||
Cash | $ | 3,773,334 | ||
Prepaid expenses | 1,012,703 | |||
Total current assets | 4,786,037 | |||
Investments held in Trust Account | 550,084,920 | |||
Total Assets | $ | 554,870,957 | ||
Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit: | ||||
Current liabilities: | ||||
Accrued expenses | $ | 16,878 | ||
Franchise tax payable | 141,968 | |||
Total current liabilities | 158,846 | |||
Derivative warrant liabilities | 21,510,000 | |||
Deferred underwriting commissions | 19,250,000 | |||
Total liabilities | 40,918,846 | |||
Commitments and Contingencies | 0 | |||
Class A common stock subject to possible redemption, $0.0001 par value; 55,000,000 shares at $10.00 per share | 550,000,000 | |||
Stockholders’ Deficit: | ||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0ne issued and outstanding | 0— | |||
Class A common stock, $0.0001 par value; 80,000,000 shares authorized,0ne issued or outstanding excluding 55,000,000 shares subject to possible redemption | 0 | |||
Class B common stock, $0.0001 par value; 19,000,000 shares authorized; 2,750,000 shares issued and outstanding | 275 | |||
Additional paid-in capital | 0 | |||
Accumulated deficit | (36,048,164 | ) | ||
Total stockholders’ deficit | (36,047,889 | ) | ||
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit | $ | 554,870,957 | ||
Three Months Ended September 30, 2021 | The Period From January 11, 2021 (inception) through September 30, 2021 | |||||||
General and administrative expenses | $ | 376,676 | $ | 865,711 | ||||
General and administrative expenses - related party | 300,000 | 629,589 | ||||||
Franchise tax expenses | 49,863 | 141,968 | ||||||
Loss from operations | (726,539 | ) | (1,637,268 | ) | ||||
Other income (expense) | ||||||||
Change in fair value of derivative warrant liabilities | 11,640,000 | 20,800,000 | ||||||
Financing costs - derivative warrant liabilities | 0 | (1,410,520 | ) | |||||
Income from investments held in Trust account | 48,101 | 84,920 | ||||||
Net income | $ | 10,961,562 | $ | 17,837,132 | ||||
Basic and diluted weighted average outstanding of Class A common stock | 55,000,000 | 41,791,339 | ||||||
Basic and diluted net income per share, Class A common stock | $ | 0.19 | $ | 0.40 | ||||
Basic weighted average shares outstanding, Class B common stock | 2,750,000 | 2,689,961 | ||||||
Diluted weighted average shares outstanding, Class B common stock | 2,750,000 | 2,750,000 | ||||||
Basic and diluted net income per share, Class B common stock | $ | 0.19 | $ | 0.40 | ||||
June 30, 2022 | December 31, 2021 | |||||||
Assets: | (unaudited | ) | ||||||
Current assets: | ||||||||
Cash | $ | 2,028,571 | $ | 3,375,154 | ||||
Prepaid expenses | 540,103 | 836,448 | ||||||
Total current assets | 2,568,674 | 4,211,602 | ||||||
Investments held in Trust Account | 550,692,144 | 550,153,304 | ||||||
Total Assets | $ | 553,260,818 | $ | 554,364,906 | ||||
Commitments and Contingencies | 0 | 0 | ||||||
Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit: | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 92,989 | $ | 67,292 | ||||
Accrued expenses | 19,500 | 16,875 | ||||||
Franchise tax payable | 16,146 | 194,571 | ||||||
Income tax payable | 91,227 | — | ||||||
Total current liabilities | 219,862 | 278,738 | ||||||
Derivative warrant liabilities | 5,520,000 | 17,370,000 | ||||||
Deferred underwriting commissions | 19,250,000 | 19,250,000 | ||||||
Total liabilities | 24,989,862 | 36,898,738 | ||||||
Class A common stock subject to possible redemption, $0.0001 par value; 55,000,000 shares issued and outstanding at $10.004 and $10.00 per share redemption value at June 30, 2022 and December 31, 2021, respectively | 550,243,186 | 550,000,000 | ||||||
Stockholders’ Deficit: | ||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; NaN issued or outstanding at June 30, 2022 and December 31, 2021 | 0— | 0— | ||||||
Class A common stock subject to possible redemption, $0.0001 par value; 80,000,000 shares authorized,0 non-redeemable shares issued or outstanding at June 30, 2022 and December 31, 2021 | — | — | ||||||
Class B common stock, $0.0001 par value; 19,000,000 shares authorized; 2,750,000 shares issued and outstanding at June 30, 2022 and December 31, 2021 | 275 | 275 | ||||||
Additional paid-in capital | — | — | ||||||
Accumulated deficit | (21,972,505 | ) | (32,534,107 | ) | ||||
Total stockholders’ deficit | (21,972,230 | ) | (32,533,832 | ) | ||||
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit | $ | 553,260,818 | $ | 554,364,906 | ||||
Common Stock | Accumulated Deficit | Total | ||||||||||||||||||||||||||
Class A | Class B | Additional Paid-In | Stockholders’ | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | |||||||||||||||||||||||
Balance - January 11, 2021 (inception) | — | $ | — | — | $ | — | $ | 0 | $ | 0 | $ | — | ||||||||||||||||
Issuance of Class B common stock to Initial Stockholders | — | — | 2,875,000 | 288 | 24,712 | 0 | 25,000 | |||||||||||||||||||||
Forfeiture of Class B common stock | — | — | (125,000 | ) | (13 | ) | 13 | 0 | — | |||||||||||||||||||
Accretion of Class A common stock to redemption amount | — | — | — | — | (24,725 | ) | (53,885,296 | ) | (53,910,021 | ) | ||||||||||||||||||
Net loss | — | — | — | — | 0 | (12,380,947 | ) | (12,380,947 | ) | |||||||||||||||||||
Balance - March 31, 2021 (unaudited) | 0 | $ | 0 | 2,750,000 | $ | 275 | $ | 0 | $ | (66,266,243 | ) | $ | (66,265,968 | ) | ||||||||||||||
Net income | — | — | — | — | 0 | 19,256,517 | 19,256,517 | |||||||||||||||||||||
Balance - June 30, 2021 (unaudited) | 0 | $ | 0 | 2,750,000 | $ | 275 | $ | 0 | $ | (47,009,726 | ) | $ | (47,009,451 | ) | ||||||||||||||
Net income | — | — | — | — | 0 | 10,961,562 | 10,961,562 | |||||||||||||||||||||
Balance - September 30, 2021 (unaudited) | 0 | $ | 0 | 2,750,000 | $ | 275 | $ | 0 | $ | (36,048,164 | ) | $ | (36,047,889 | ) | ||||||||||||||
For the Three Months Ended June 30 | For the Six Months Ended June 30, 2022 | Period From January 11, 2021 (inception) through June 30, 2021 | ||||||||||||||
2022 | 2021 | |||||||||||||||
General and administrative expenses | $ | 645,657 | $ | 766,172 | $ | 1,429,664 | $ | 818,623 | ||||||||
Franchise tax expenses | 49,316 | 49,315 | 63,161 | 92,105 | ||||||||||||
Loss from operations | (694,973 | ) | (815,487 | ) | (1,492,825 | ) | (910,728 | ) | ||||||||
Other income (expense) | ||||||||||||||||
Change in fair value of derivative warrant liabilities | 4,830,000 | 20,050,000 | 11,850,000 | 9,160,000 | ||||||||||||
Financing costs - derivative warrant liabilities | — | — | — | (1,410,520 | ) | |||||||||||
Income from investments held in Trust account | 469,840 | 22,004 | 538,840 | 36,818 | ||||||||||||
Income before income tax expense | $ | 4,604,867 | $ | 19,256,517 | $ | 10,896,015 | $ | 6,875,570 | ||||||||
Income tax expense | 91,227 | — | 91,227 | — | ||||||||||||
Net income | $ | 4,513,640 | $ | 19,256,517 | $ | 10,804,788 | $ | 6,875,570 | ||||||||
Basic and diluted weighted average outstanding of Class A common stock | 55,000,000 | 55,000,000 | 55,000,000 | 34,290,123 | ||||||||||||
Basic and diluted net income per share, Class A common stock | $ | 0.08 | $ | 0.33 | $ | 0.19 | $ | 0.19 | ||||||||
Basic and diluted weighted average shares outstanding, Class B common stock | 2,750,000 | 2,750,000 | 2,750,000 | 2,655,864 | ||||||||||||
Basic and diluted net income per share, Class B common stock | $ | 0.08 | $ | 0.33 | $ | 0.19 | $ | 0.19 | ||||||||
Cash Flows from Operating Activities: | ||||
Net income | $ | 17,837,132 | ||
Adjustments to reconcile net income to net cash used in operating activities: | ||||
Income from investments held in Trust account | (84,920 | ) | ||
Financing cost - derivative warrant liabilities | 1,410,520 | |||
Change in fair value of derivative warrant liabilities | (20,800,000 | ) | ||
Changes in operating assets and liabilities: | ||||
Prepaid expenses | (1,012,703 | ) | ||
Accrued expenses | 16,878 | |||
Franchise tax payable | 141,968 | |||
Net cash used in operating activities | (2,491,125 | ) | ||
Cash Flows from Investing Activities | ||||
Cash deposited in Trust Account | (550,000,000 | ) | ||
Net cash used in investing activities | (550,000,000 | ) | ||
Cash Flows from Financing Activities: | ||||
Proceeds from issuance of Class B common stock to Initial Stockholders | 25,000 | |||
Proceeds from note payable to related party | 276,543 | |||
Repayment of note payable to related party | (276,543 | ) | ||
Proceeds received from initial public offering, gross | 550,000,000 | |||
Proceeds received from private placement | 18,000,000 | |||
Offering costs paid | (11,760,541 | ) | ||
Net cash provided by financing activities | 556,264,459 | |||
Net increase in cash | 3,773,334 | |||
Cash - beginning of the period | 0 | |||
Cash - end of the period | $ | 3,773,334 | ||
Supplemental disclosure of noncash financing activities: | ||||
Deferred underwriting commissions in connection with the initial public offering | $ | 19,250,000 | ||
Accretion of Class A common stock to redemption amount | $ | 53,910,021 |
Common Stock | Total Stockholders’ | |||||||||||||||||||||||||||
Class A | Class B | Additional Paid-In | Accumulated Deficit | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | |||||||||||||||||||||||
Balance - December 31, 2021 | — | $ | — | 2,750,000 | $ | 275 | $ | — | $ | (32,534,107 | ) | $ | (32,533,832 | ) | ||||||||||||||
Net income | — | — | — | — | — | 6,291,148 | 6,291,148 | |||||||||||||||||||||
Balance - March 31, 2022 (unaudited) | — | $ | — | 2,750,000 | $ | 275 | $ | — | $ | (26,242,959 | ) | $ | (26,242,684 | ) | ||||||||||||||
Increase in redemption value of Class A ordinary shares subject to possible redemption | — | — | — | — | — | (243,186 | ) | (243,186 | ) | |||||||||||||||||||
Net income | — | — | — | — | — | 4,513,640 | 4,513,640 | |||||||||||||||||||||
Balance - June 30, 2022 (unaudited) | — | $ | — | 2,750,000 | $ | 275 | $ | — | $ | (21,972,505 | ) | $ | (21,972,230 | ) | ||||||||||||||
Common Stock | Total Stockholders’ | |||||||||||||||||||||||||||
Class A | Class B | Additional Paid-In | Accumulated Deficit | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Capital | Deficit | |||||||||||||||||||||||
Balance - January 11, 2021 (inception) | — | $ | — | — | $ | — | $ | — | $ | — | $ | — | ||||||||||||||||
Issuance of Class B common stock to Initial Stockholders | — | — | 2,875,000 | 288 | 24,712 | — | 25,000 | |||||||||||||||||||||
Forfeiture of Class B common stock | — | — | (125,000 | ) | (13 | ) | 13 | — | — | |||||||||||||||||||
Accretion of Class A common stock to redemption amount | — | — | — | — | (24,725 | ) | (53,885,296 | ) | (53,910,021 | ) | ||||||||||||||||||
Net loss | — | — | — | — | — | (12,380,947 | ) | (12,380,947 | ) | |||||||||||||||||||
Balance - March 31, 2021 (unaudited) | — | $ | — | 2,750,000 | $ | 275 | $ | — | $ | (66,266,243 | ) | $ | (66,265,968 | ) | ||||||||||||||
Net income | — | — | — | — | — | 19,256,517 | 19,256,517 | |||||||||||||||||||||
Balance - June 30, 2021 (unaudited) | — | $ | — | 2,750,000 | $ | 275 | $ | — | $ | (47,009,726 | ) | $ | (47,009,451 | ) | ||||||||||||||
For the Six Months Ended June 30, 2022 | For the period From January 11, 2021 (inception) through June 30, 2021 | |||||||
Cash Flows from Operating Activities: | ||||||||
Net income | $ | 10,804,788 | $ | 6,875,570 | ||||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
Income from investments held in Trust account | (538,840 | ) | (36,818 | ) | ||||
Financing cost - derivative warrant liabilities | — | 1,410,520 | ||||||
Change in fair value of derivative warrant liabilities | (11,850,000 | ) | (9,160,000 | ) | ||||
Changes in operating assets and liabilities: | ||||||||
Prepaid expenses | 296,345 | (1,190,735 | ) | |||||
Accounts payable | 25,697 | 20,576 | ||||||
Accrued expenses | 2,625 | 5,000 | ||||||
Franchise tax payable | (178,425 | ) | 92,105 | |||||
Income tax payable | 91,227 | — | ||||||
Net cash used in operating activities | (1,346,583 | ) | (1,983,782 | ) | ||||
Cash Flows from Investing Activities | ||||||||
Cash deposited in Trust Account | — | (550,000,000 | ) | |||||
Net cash used in investing activities | — | (550,000,000 | ) | |||||
Cash Flows from Financing Activities: | ||||||||
Proceeds from issuance of Class B common stock to Initial Stockholders | — | 25,000 | ||||||
Proceeds from note payable to related party | — | 276,543 | ||||||
Repayment of note payable to related party | — | (276,543 | ) | |||||
Proceeds received from initial public offering, gross | — | 550,000,000 | ||||||
Proceeds received from private placement | — | 18,000,000 | ||||||
Offering costs paid | — | (11,760,541 | ) | |||||
Net cash provided by financing activities | — | 556,264,459 | ||||||
Net change in cash | (1,346,583 | ) | 4,280,677 | |||||
Cash - beginning of the period | 3,375,154 | — | ||||||
Cash - end of the period | $ | 2,028,571 | $ | 4,280,677 | ||||
Supplemental disclosure of noncash financing activities: | ||||||||
Deferred underwriting commissions in connection with the initial public offering | $ | — | $ | 19,250,000 |
For the Three Months Ended September 30, 2021 | The Period From January 11, 2021 (inception) through September 30, 2021 | |||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||
Basic and diluted net income per common stock: | ||||||||||||||||
Numerator: | ||||||||||||||||
Allocation of net income—Basic | $ | 10,439,583 | $ | 521,979 | $ | 16,758,450 | $ | 1,078,682 | ||||||||
Allocation of net income—Diluted | $ | 10,439,583 | $ | 521,979 | $ | 16,735,860 | $ | 1,101,272 | ||||||||
Denominator: | ||||||||||||||||
Basic weighted average common stock outstanding | 55,000,000 | 2,750,000 | 41,791,339 | 2,689,961 | ||||||||||||
Diluted weighted average common stock outstanding | 55,000,000 | 2,750,000 | 41,791,339 | 2,750,000 | ||||||||||||
Basic net income per common stock | $ | 0.19 | $ | 0.19 | $ | 0.40 | $ | 0.40 | ||||||||
Diluted net income per common stock | $ | 0.19 | $ | 0.19 | $ | 0.40 | $ | 0.40 | ||||||||
For the Three Months Ended June 30, 2022 | For the Three Months Ended June 30, 2021 | |||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||
Basic and diluted net income per common stock: | ||||||||||||||||
Numerator: | ||||||||||||||||
Allocation of net income - Basic and diluted | $ | 4,298,705 | $ | 214,935 | $ | 18,339,540 | $ | 916,977 | ||||||||
Denominator: | ||||||||||||||||
Basic and diluted weighted average common stock outstanding | 55,000,000 | 2,750,000 | 55,000,000 | 2,750,000 | ||||||||||||
Basic and diluted net income per common stock | $ | 0.08 | $ | 0.08 | $ | 0.33 | $ | 0.33 | ||||||||
For the Six Months Ended June 30, 2022 | Period From January 11, 2021 (inception) through June 30, 2021 | |||||||||||||||
Class A | Class B | Class A | Class B | |||||||||||||
Basic and diluted net income per common stock: | ||||||||||||||||
Numerator: | ||||||||||||||||
Allocation of net income - Basic and diluted | $ | 10,290,274 | $ | 514,514 | $ | 6,381,319 | $ | 494,251 | ||||||||
Denominator: | ||||||||||||||||
Basic and diluted weighted average common stock outstanding | 55,000,000 | 2,750,000 | 34,290,123 | 2,655,864 | ||||||||||||
Basic and diluted net income per common stock | $ | 0.19 | $ | 0.19 | $ | 0.19 | $ | 0.19 | ||||||||
• | if, and only if, the last sales price of shares of the Class A common stock equals or exceeds $45.00 per share for any 20 trading days within a 30 trading day period (the “30-day trading period”) ending three business days before the Company sends the notice of redemption, and |
• | if, and only if, there is a current registration statement in effect with respect to the shares of Class A common stock underlying such warrants commencingfive business days prior to the 30-day trading period and continuing each day thereafter until the date of redemption. |
Gross Proceeds | $ | 550,000,000 | $ | 550,000,000 | ||||
Less: | ||||||||
Proceeds allocated to Public Warrants | (24,310,000 | ) | (24,310,000 | ) | ||||
Class A common stock issuance costs | (29,600,021 | ) | (29,600,021 | ) | ||||
Plus: | ||||||||
Accretion of carrying value to redemption value | 53,910,021 | 53,910,021 | ||||||
Class A common stock subject to possible redemption | $ | 550,000,000 | ||||||
Class A common stock subject to possible redemption at December 31, 2021 | $ | 550,000,000 | ||||||
Increase in redemption value of Class A ordinary shares subject to redemption | 243,186 | |||||||
Class A common stock subject to possible redemption at June 30, 2022 | $ | 550,243,186 | ||||||
Fair Value Measured as of September 30, 2021 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets | ||||||||||||||||
Investments held in Trust Account | $ | 550,084,920 | $ | — | $ | — | $ | 550,084,920 | ||||||||
Liabilities: | ||||||||||||||||
Derivative public warrant liabilities | $ | 10,230,000 | $ | — | $ | — | $ | 10,230,000 | ||||||||
Derivative private warrant liabilities | $ | — | $ | — | $ | 11,280,000 | $ | 11,280,000 |
Fair Value Measured as of June 30, 2022 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets | ||||||||||||||||
Investments held in Trust Account (1) | $ | 550,692,144 | $ | — | $ | — | $ | 550,692,144 | ||||||||
Liabilities: | ||||||||||||||||
Derivative public warrant liabilities | $ | 2,640,000 | $ | — | $ | — | $ | 2,640,000 | ||||||||
Derivative private warrant liabilities | $ | — | $ | 2,880,000 | $ | — | $ | 2,880,000 |
(1) | Includes approximately $5,000 of cash. |
Fair Value Measured as of December 31, 2021 | ||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets | ||||||||||||||||
Investments held in Trust Account (2) | $ | 550,153,304 | $ | — | $ | — | $ | 550,153,304 | ||||||||
Liabilities: | ||||||||||||||||
Derivative public warrant liabilities | $ | 8,250,000 | $ | — | $ | — | $ | 8,250,000 | ||||||||
Derivative private warrant liabilities | $ | — | $ | — | $ | 9,120,000 | $ | 9,120,000 |
(2) | Includes approximately $900 of cash. |
As of September 30, | ||||
Exercise price | 11.50 | |||
Stock Price | ||||
Option term (in years) | 5.00 | |||
Volatility | % | |||
Risk-free interest rate | % |
Derivative warrant liabilities at January 11, 2021 | $ | 0 | ||
Issuance of Derivative Warrants (level 3) | 56,230,000 | |||
Change in fair value of derivative warrant liabilities - Level 3 | (3,030,000 | ) | ||
Derivative warrant liabilities at March 31, 2021 - Level 3 | $ | 53,200,000 | ||
Transfer of Public Warrants to Level 1 | (23,320,000 | ) | ||
Change in fair value of derivative warrant liabilities - Level 3 | (12,240,000 | ) | ||
Derivative warrant liabilities at June 30, 2021 - Level 3 | $ | 17,640,000 | ||
Change in fair value of derivative warrant liabilities - Level 3 | (6,360,000 | ) | ||
Derivative warrant liabilities at September 30, 2021 - Level 3 | $ | 11,280,000 | ||
Derivative warrant liabilities at December 31, 2021 - Level 3 | $ | 9,120,000 | ||
Transfer of Private Warrants to Level 2 | (9,120,000 | ) | ||
Derivative warrant liabilities at June 30, 2022 - Level 3 | $ | — | ||
Derivative warrant liabilities at January 11, 2021 | $ | — | ||
Issuance of Derivative Warrants (level 3) | 56,230,000 | |||
Change in fair value of derivative warrant liabilities—Level 3 | (3,030,000 | ) | ||
Derivative warrant liabilities at March 31, 2021—Level 3 | 53,200,000 | |||
Transfer of Public Warrants to Level 1 | (23,320,000 | ) | ||
Change in fair value of derivative warrant liabilities—Level 3 | (12,240,000 | ) | ||
Derivative warrant liabilities at June 30, 2021—Level 3 | $ | 17,640,000 | ||
Inline XBRL Taxonomy Extension Schema Document | ||
Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||
Inline XBRL Taxonomy Extension Definition Linkbase Document | ||
Inline XBRL Taxonomy Extension Label Linkbase Document | ||
Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* | Filed herewith. |
** | Furnished herewith. |
REVOLUTION HEALTHCARE ACQUISITION CORP. | ||
By: | /s/ Jay Markowitz, M.D. | |
Name: | Jay Markowitz, M.D. | |
Title: | Chief Executive Officer | |
REVOLUTION HEALTHCARE ACQUISITION CORP. | ||
By: | /s/ Mark McDonnell | |
Name: | Mark McDonnell | |
Title: | Chief Financial Officer (Principal Financial Officer) |